From: Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia
All countries | Uzbekistan | Tajikistan | Kyrgystan | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. strains | % | SD | No. strains | % | SD | No. strains | % | SD | No. strains | % | SD | |
Samples | 607 | 235 | 38.7 | 206 | 33.9 | 166 | 27.3 | |||||
Gender | ||||||||||||
Male | 359 | 59.1 | 139 | 59.1 | 120 | 58.3 | 100 | 60.2 | ||||
Female | 239 | 39.4 | 96 | 40.9 | 85 | 41.3 | 58 | 34.9 | ||||
Unknown | 9 | 0 | 1 | 8 | ||||||||
Age a | ||||||||||||
Mean | 37.94 | 15.67 | 42.91 | 16.6 | 34.53 | 14.36 | 34.18 | 13.49 | ||||
Treatment | ||||||||||||
New | 333 | 54.9 | 156 | 66.4 | 93 | 45.1 | 84 | 50.6 | ||||
Previous | 221 | 36.4 | 79 | 33.6 | 113 | 54.9 | 29 | 17.5 | ||||
Unknown | 53 | 0 | 0 | 53 | ||||||||
MIRU lineage | ||||||||||||
Beijing | 411 | 67.7 | 136 | 57.9 | 154 | 74.8 | 121 | 72.9 | ||||
Dehli/CAS | 6 | 1 | 6 | 2.6 | ||||||||
H37Rv-like | 60 | 9.9 | 31 | 13.2 | 12 | 5.8 | 17 | 10.2 | ||||
LAM | 36 | 5.9 | 22 | 9.4 | 5 | 2.4 | 9 | 5.4 | ||||
NEW-1 | 31 | 5.1 | 16 | 6.8 | 10 | 4.9 | 5 | 3 | ||||
URAL | 28 | 4.6 | 10 | 4.3 | 11 | 5.3 | 7 | 4.2 | ||||
Haarlem | 26 | 4.3 | 7 | 3 | 13 | 6.3 | 6 | 3.6 | ||||
S-type | 3 | 0.5 | 2 | 0.9 | 1 | 0.6 | ||||||
TUR | 1 | 0.2 | 1 | 0.5 | ||||||||
X-type | 1 | 0.2 | 1 | 0.4 | ||||||||
Undefined | 4 | 0.7 | 4 | 1.7 | ||||||||
MLVA MtbC15–9 | ||||||||||||
94–32 (Beijing) | 145 | 23.9 | 58 | 24.7 | 49 | 23.8 | 38 | 22.9 | ||||
100–32 (Beijing) | 70 | 11.5 | 12 | 5.1 | 51 | 24.8 | 7 | 4.2 | ||||
Resistance pattern | ||||||||||||
Pan-susceptible | 35 | 5.8 | 21 | 8.9 | 2 | 1 | 12 | 7.2 | ||||
Other resistances | 279 | 46 | 127 | 54 | 66 | 32 | 86 | 51.8 | ||||
MDR-TB | 172 | 28.3 | 47 | 20 | 71 | 34.5 | 54 | 32.5 | ||||
Pre XDR-TB | 94 | 15.5 | 34 | 14.5 | 50 | 24.3 | 10 | 6 | ||||
XDR-TB | 27 | 4.4 | 6 | 2.6 | 17 | 8.3 | 4 | 2.4 |